Related Experiment Video
Updated: May 31, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Herbal Medicines as Complementary Therapy for Managing Complications in COVID-19 Patients with Diabetes Mellitus
Syah Akbarul Adha1, Nadiya Nurul Afifah1,2, Irma Rahayu Latarissa3,4
1Department of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia.
Insights
Several herbal medicines show potential as complementary treatments for COVID-19 complications in Diabetes Mellitus patients. Further research is needed to validate these findings in clinical settings.
Area of Science:
- Integrative Medicine
- Pharmacology
- Immunology
Background:
- Diabetes Mellitus (DM) is characterized by hyperglycemia and inflammation, increasing susceptibility to infections like Coronavirus Disease 2019 (COVID-19).
- Effective treatments for COVID-19 in DM patients are lacking, highlighting the need for novel therapeutic strategies.
- Herbal medicines possess diverse pharmacological properties, including antidiabetic, antiviral, and anti-inflammatory effects, making them candidates for complementary therapy.
Purpose of the Study:
- To investigate the potential of herbal medicines as complementary therapies for Diabetes Mellitus patients experiencing COVID-19 complications.
- To review existing in-vitro and in-vivo evidence on the efficacy of various medicinal plants.
Main Methods:
- A literature review was conducted, analyzing articles published within the last 15 years.
- Keywords used included 'herbal medicines', 'COVID-19', 'Diabetes Mellitus', 'antidiabetics', 'antiviral', and 'anti-inflammatory'.
Main Results:
- Ten specific herbal medicines demonstrated potential as complementary treatments: Andrographis paniculata, Ageratum conyzoides, Artocarpus altilis, Centella asiatica, Momordica charantia, Persea gratissima, Phyllanthus urinaria, Physalis angulata, Tinospora cordifolia, and Zingiber zerumbet.
- These herbs exhibited relevant antidiabetic, antiviral, and anti-inflammatory properties.
Conclusions:
- Herbal medicines may offer a complementary therapeutic approach for managing COVID-19 in Diabetes Mellitus patients.
- Experimental validation in infection models and clinical trials is essential to confirm the efficacy and safety of these herbal remedies.
Abstract:
Diabetes mellitus (DM) is recognized and classified as a group of conditions marked by persistent high blood glucose levels. It is also an inflammatory condition that may influence concurrent disease states, including Coronavirus Disease 2019 (COVID-19). Currently, no effective drug has been found to treat COVID-19, especially in DM patients. Many herbal medicines, such as the well-known Andrographis paniculata, have been explored as drugs and complementary therapies due to their antidiabetic, antibacterial, antiviral, anti-inflammatory, and immunomodulatory effects. This study aimed to examine the potential of herbal medicines as complementary therapy in DM patients with COVID-19 complications, drawing from in-vitro and in-vivo investigations. This study analyzed articles published within the last 15 years using keywords including "herbal medicines", "COVID-19", "Diabetes Mellitus", "antidiabetics", "antiviral", and "anti-inflammatory". The results showed that several herbal medicines could serve as complementary therapy for DM patients with COVID-19 complications. These include Andrographis paniculata, Ageratum conyzoides, Artocarpus altilis, Centella asiatica, Momordica charantia, Persea gratissima, Phyllanthus urinaria, Physalis angulata, Tinospora cordifolia, and Zingiber zerumbet. Herbal medicines may serve as a complementary therapy for DM patients with COVID-19, but these claims need experimental validation in infection models and among affected patients.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes Mellitus: Type 2 and Gestational
Oral Hypoglycemic Agents: Biguanides and Glitazones

